TNGX
Tango Therapeutics, Inc.NASDAQHealthcare$21.63-6.20%ClosedMarket Cap: $2.51B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
1
Sales
2
Buy/Sell Ratio
0.50
Total Bought
$0.00
Total Sold
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | Crystal Adam | officer: President, R&D | Sell | 27,000 | $21.20 | 112,622 |
| Thu Apr 02 | Crystal Adam | officer: President, R&D | Sell | 27,000 | $5.20 | 433,500 |
| Fri Mar 27 | Crystal Adam | officer: President, R&D | Sell | 12,000 | $5.20 | 460,500 |
| Fri Mar 27 | Crystal Adam | officer: President, R&D | Sell | 12,000 | $20.11 | 112,622 |
| Mon Mar 09 | Crystal Adam | officer: President, R&D | Sell | 20,251 | $15.00 | 112,622 |
| Fri Feb 27 | Crystal Adam | officer: President, R&D | Sell | 54,345 | $12.77 | 132,873 |
| Wed Feb 04 | Weber Barbara | director, officer: Director, Executive Chair | Sell | 37,522 | $0.00 | 1,659,773 |
| Wed Feb 04 | Weber Barbara | director, officer: Director, Executive Chair | Sell | 30,186 | $12.26 | 1,629,587 |
| Wed Feb 04 | Weber Barbara | director, officer: Director, Executive Chair | Sell | 333 | $12.90 | 1,629,254 |
| Wed Feb 04 | Beckman Daniella | officer: Chief Financial Officer | Sell | 113 | $12.90 | 184,297 |
| Wed Feb 04 | Beckman Daniella | officer: Chief Financial Officer | Sell | 10,204 | $12.26 | 184,410 |
| Wed Feb 04 | Beckman Daniella | officer: Chief Financial Officer | Sell | 44,330 | $0.00 | 194,614 |
| Wed Feb 04 | Beckman Daniella | officer: Chief Financial Officer | Sell | 265,980 | $11.94 | 265,980 |
| Wed Feb 04 | Weber Barbara | director, officer: Director, Executive Chair | Sell | 222,132 | $11.94 | 222,132 |